Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AA4500 in Peyronie's Disease
NCT01685437Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Sep 2012
- Primary completion
- Dec 2013
- Modality
- Therapeutic Enzymes
01
Overview
A Phase 3 trial of collagenase clostridium histolyticum in Peyronie's disease, sponsored by Endo International plc. Started Sep 2012; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT01685437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01685437.